Portal de Periódicos da CAPES

The 5‐HT 1B Receptors

1990; Wiley; Volume: 600; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1990.tb16878.x

1749-6632

Derek N. Middlemiss, Peter H. Hutson,

Neuropeptides and Animal Physiology

Annals of the New York Academy of SciencesVolume 600, Issue 1 p. 132-147 The 5-HT1B Receptors DEREK N. MIDDLEMISS, DEREK N. MIDDLEMISS Merck Sharp and Dohme Research Laboratories Neuroscience Research Centre Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, EnglandSearch for more papers by this authorPETER H. HUTSON, PETER H. HUTSON Merck Sharp and Dohme Research Laboratories Neuroscience Research Centre Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, EnglandSearch for more papers by this author DEREK N. MIDDLEMISS, DEREK N. MIDDLEMISS Merck Sharp and Dohme Research Laboratories Neuroscience Research Centre Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, EnglandSearch for more papers by this authorPETER H. HUTSON, PETER H. HUTSON Merck Sharp and Dohme Research Laboratories Neuroscience Research Centre Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, EnglandSearch for more papers by this author First published: October 1990 https://doi.org/10.1111/j.1749-6632.1990.tb16878.xCitations: 77AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Peroutka, S. J. & S. H. Snyder 1979. Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3]spiroperidol. Mol. Pharmacol. 16: 687–699. 2 Bradley, P. B., G. Engel, W. Feniuk, J. R. Fozard, P. P. A. Humphrey, D. N. Middlemiss, E. J. Mylecharane, B. P. Richardson & P. R. Saxena 1986. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576. 3 Middlemiss, D. N., M. Hibert & J. R. Fozard 1986. Drugs acting at central 5-hydroxytryptamine receptors. Ann. Rep. Med. Chem. 21: 41–50. 4 Pedigo, N. W., H. I. Yamamura & D. L. Nelson 1981. Discrimination of multiple [3H] 5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36: 220–226. 5 Hoyer, D., G. Engel & H. O. Kalkman 1985. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-) [125I] iodocyanopindolol, [3H] mesulergine and [3H]ketanserin. Eur. J. Pharmacol. 118: 13–23. 6 Heuring, R. E. & S. J. Peroutka 1987. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 7: 894–903. 7 Middlemiss, D. N. & J. R. Fozard 1983. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur. J. Pharmacol. 90: 151–153. 8 Gozlan, H., S. El Mestikawy & L. Pichat, J. Glowinski & M. Hamon 1983. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305: 140–142. 9 Verge, D., G. Daval, M. Marcinkiewicz, A. Patey, S. El Mestikawy, H. Gozlan & M. Hamon 1986. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5, 7-dihydroxytryptamine-treated rats. J. Neurosci. 6: 3474–3482. 10 Hoyer, D. 1988. Functional correlates of serotonin 5-HT1 recognition sites. J. Receptor Res. 8: 59–81. 11 Peroutka, S. J. 1986. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J. Neurochem. 47: 529–540. 12 Blurton, P. A. & M. D. Wood 1986. Identification of multiple binding sites for [3H] 5-hydroxytryptamine in the rat CNS. J. Neurochem. 46: 1392–1398. 13 Alexander, B. S. & M. D. Wood 1987. Stereoselective blockade of central [1H] 5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol. J. Pharm. Pharmacol. 39: 664–666. 14 Hoyer, D., G. Engel & H. O. Kalkman 1985. Characterization of the 5-HT1B recognition site in rat brain: Binding studies with (-) [125I] Iodocyanopindolol. Eur. J. Pharmacol. 118: 1–12. 15 Pazos, A., G. Engel & J. M. Palacios 1985. B-Adrenoceptor blocking agents recognise a subpopulation of serotonin receptors in brain. Brain Res. 343: 403–408. 16 Offord, S. J., G. A. Orduroy & A. Frazer 1988. Application of [125I]Iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat. J. Pharmacol. Exp. Ther. 244: 144–153. 17 Hamblin, M. W., K. Ariani, P. I. Adriaenssens & R. D. Ciararello 1987. [3H] Dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes. Evidence for guanine nucleotide regulation of agonist affinity states. J. Pharmacol. Exp. Ther. 243: 989–1001. 18 Weissmann, D., E. Mach, C. Oberlander, Y. Demassey & J-F. Pujol 1986. Evidence for a hyperdensity of 5HT1B binding sites in the substantia nigra of the rat after 5, 7-dihydroxytryptamine intraventricular injection. Neurochem. Int. 9: 191–200. 19 Connor, H. E., W. Feniuk, P. P. A. Humphrey & M. J. Perren 1986. 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetised cats. Br. J. Pharmacol. 87: 417–426. 20 Middlemiss, D. N. 1985. The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol. 37: 434–437. 21 Neale, R. F., S. L. Fallon, W. C. Boyar, J. W. F. Wasley, L. L. Martin, G. A. Stone, B. S. Glaeser, C. M. Sinton & M. Williams 1987. Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist. Eur. J. Pharmacol. 136: 1–9. 22 Middlemiss, D. N. 1984. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H]5-HT recognition site. Naunyn-Schmiedebergs Arch. Pharmacol. 327: 18–22. 23 Middlemiss, D. N. 1984. D. N. 1984. Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Eur. J. Pharmacol. 101: 289–293. 24 Schlicker, E., M. Göthert & K. Hillenbrand 1985. Cyanopindolol is a highly potent and selective antagonist at the presynaptic autoreceptor in the rat brain cortex. Naunyn-Schmiedebergs Arch. Pharmacol. 331: 398–401. 25 Middlemiss, D. N. 1986. Blockade of the central 5-HT autoreceptor by B-adrenoceptor antagonists. Eur J. Pharmacol. 120: 51–56. 26 Engel, G., M. Göthert, E. Muller-Schweinitzer, E. Schlicker, L. Sistonen & P. A. Stadler 1983. Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedebergs Arch. Pharmacol. 324: 116–124. 27 Maura, G., M. Ulivi & M. Raiteri 1987. (-)-Propranolol and (±)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain. Neuropharmacol. 26: 713–717. 28 Engel, G., M. Göthert, D. Hoyer, E. Schlicker & K. Hillenbrand 1986. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedebergs Arch. Pharmacol. 332: 1–7. 29 Göthert, M., E. Schlicker, K. Fink & K. Classen 1987. Effects of RU 24969 on serotonin release in rat brain cortex: Further support for the identity of serotonin autoreceptors with 5-HT1B sites. Arch. Int. Pharmacodyn. 288: 31–42. 30 Bonanno, G., G. Maura & M. Raiteri 1986. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. Eur. J. Pharmacol. 126: 317–321. 31 Raiteri, M., G. Maura, G. Bonanno & A. Pittaluga 1986. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J. Pharm. Exp. Ther. 237: 644–648. 32 Hibert, M. & D. N. Middlemiss 1986. Stereoselective blockade at the 5-HT autoreceptor and inhibition of radioligand binding to central 5-HT recognition sites by the optical isomers of methiothepin. Neuropharmacology. 25: 1–4. 33 Waldmeier, P. C., M. Williams, P. A. Baumann, S. Bischoff, M. A. Sills & R. F. Neale 1988. Interactions of isamoltane (CGP 361 A), an anxiolytic phenoxy propranolamine derivative, with 5-HT1 receptor subtypes in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 337: 609–620. 34 Maura, G. & M. Raiteri 1986. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 129: 333–337. 35 Maura, G., E. Roccatagliata & M. Raiteri 1986. Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn-Schmiedebergs Arch. Pharmacol. 334: 323–326. 36 Bouhelal, R., L. Smounya & J. Bockaert 1988. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur J. Pharmacol. 151: 189–196. 37 Senwen, K., I. Magnaldo & J. Ponyssegur 1988. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature 335: 254–256. 38 Stratford, C. A., G. L. Tan, M. W. Hamblin & R. D. Ciaranello 1988. Differential inactivation and G protein reconsititution of subtypes of [3H]-hydroxytryptamine binding sites in brain. Mol. Pharmacol. 34: 527–536. 39 Holt, S. E., M. Cooper & J. H. Wyllie 1986. On the nature of the receptor mediating the action of 5-hydroxytryptamine in potentiating responses of the mouse urinary bladder strip to electrical stimulation. Naunyn-Schmiedebergs Arch. Pharmacol. 334: 333–340. 40 Wyllie, J. H. 1989. Blockade by cyanopinodolol of 5-HT receptors in mouse urinary bladder. In Serotonin from Cell Biology to Pharmacology and Therapeutics. Serotonin Club, Florence , Italy 56. 41 Molderings, G. J., K. Fink, E. Schlicker & M. Göthert 1987. Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava, Naunyn-Schmiedebergs Arch. Pharmacol. 336: 245–250. 42 Carlsson, A., W. Kehr, M. Lindquist, T. Magnusson & C. Atack 1972. Regulation of monoamine metabolism in the central nervous system. Pharmacol. Rev. 24: 371–384. 43 Euvrard, C. & J. R. Boissier 1980. Biochemical assessment of the central 5-HT agonist activity of RU24969 (A piperidinyl indole). Eur. J. Pharmacol. 63: 65–72. 44 Brazell, M. P., C. A. Marsden, A. P. Nisbet & C. Routledge 1985. The 5-HT1 receptor agonist RU 24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Br. J. Pharmacol. 86: 209–218. 45 Sharp, T., S. R. Bramwell & D. G. Grahame-Smith 1989. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in-vivo as determined by brain microdialysis. Br. J. Pharmacol. 96: 283–290. 46 Rokosz-Pele, A., L. Antkiewicz-Michaluk & J. Vetulani 1980. 5-Hydroxytryptamine-like properties of M-chlorophenyl piperazine: Comparison with quipazine. J. Pharm Pharmac. 32: 220–222. 47 Fuller, R. W., H. D. Snoddy, N. R. Mason & B. B. Molloy 1978. Effect of 1-(m-trifluoro methyl phenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in-vitro and on serotonin turnover in rat brain in vivo. Eur. J. Pharmacol. 52: 11–16. 48 Hjorth, S., A. Carlsson, P. Lindberg, D. Sanchez, H. Wikstrom, L. E. Arvidsson, U. Hacksell & J. L. G. Nilsson 1982. 8-hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT, a potent and selective simplified ergot cogener with central 5-HT receptor stimulating activity. J. Neural Trans. 55: 169–188. 49 Van de Kar, L. D.. S. A. Lorens, J. H. Urban & C. L. Bethea 1989. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonists on prolactin secretion. Neuropharmacology 28: 299–305. 50 Fuller, R. W., H. D. Snoody, N. R. Mason, S. K. Hemrick-Luecke & J. A. Clemens 1981. Substituted piperazines as central serotonin agonists: Comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethyl phenylpiperazine. J. Pharmacol. Exp. Ther. 218: 636–641. 51 Fuller, R. W., H. D. Snoddy, N. R. Mason & J. E. Owen 1981. Disposition and pharmacological effects of m-chlorophenylpiperazine in rats. Neuropharmacology 20: 155–162. 52 Koenig, J. I., G. A. Gudelsky & H. Y. Meltzer 1987. Stimulation of corticosterone and B-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur. J. Pharmacol. 137: 1–8. 53 Carlsson, M. & E. Eriksson 1986. A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin, has different effects on prolactin secretion in male and female rats. Acta Pharmacol. Toxicol. 58: 297–302. 54 Mueller, E. A., D. L. Murphy & T. Sunderland 1986. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology. 89: 388–391. 55 Sinton, C. M. & S. L. Fallon 1988. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur. J. Pharmacol. 157: 173–181. 56 Sprouse, J. S. & G. K. Aghajanian 1987. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1: 3–9. 57 Sprouse, J. S. & G. K. Aghajanian 1988. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neurones. Neuropharmacology 27: 707–715. 58 Chaput, Y., P. Blier & C. de Montigny 1986. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J. Neurosci. 6: 2796–2801. 59 Lucki, I. & A. Frazer 1985. Changes in behaviour associated with serotonin receptors following repeated treatment of rats with antidepressant drugs. In Behavioural Pharmacology: Current Status. L.S. Seiden & R.L. Balster, Eds. New York : Alan Liss, 339–357. 60 Lucki, I. & A. Frazer 1982. Behavioural effects of indole and piperazine-type serotonin receptor agonists. Soc. Neurosci Abst. 8: 101. 61 Kennett, G. A. & G. Curzon 1988. Evidence that MCPP may have behavioural effects mediated by central 5-HT1C receptors. Br. J. Pharmacol. 94: 137–147. 62 Green, A. R., A. P. Guy & C. R. Gardiner 1984. The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatments with antidepressants. Neuropharmacology 23: 655–661. 63 Oberlander, C., B. Blaquiere & J. F. Pujol 1986. Distinct functions for dopamine and serotonin in locomotor behaviour: Evidence using the 5-HT1 agonist RU 24969 in globus pallidus lesioned rats. Neurosci. Lett. 67: 113–118. 64 Tricklebank, M. D., D. N. Middlemiss & J. Neill 1986. Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat. Neuropharmacology 25: 877–886. 65 Sugrue, M. F. 1987. Neuropharmacology of drugs affecting food intake. Pharmacol Ther. 32: 145–182. 66 Kennett, G. A. & G. Curzon 1988. Evidence that hypophagia induced by MCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology. 96: 93–100. 67 Kennett, G. A., C. T. Dourish & G. Curzon 1987. 5-HT1B agonists induce anorexia at a post-synaptic site. Eur. J. Pharmacol. 141: 429–435. 68 Dourish, C. T., P. H. Hutson & G. Curzon 1985. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86: 197–204. 69 Hutson, P. H., T. P. Donohoe & G. Curzon 1986. Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoro methyl phenyl)piperazinc (LY 165163) at central 5-HT receptors. Eur. J. Pharmacol. 138: 215–223. 70 Hutson, P. H., C. T. Dourish & G. Curzon 1988. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT by 5-HT cell body autoreceptors. Eur. J. Pharmacol. 129: 347–352. 71 Hutson, P. H., T. P. Donohoe & G. Curzon 1988. Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95: 550–552. 72 Berendsen, H. H. G. & C. L. E. Broekkamp 1987. Drug induced penile erections in rats: Indications of serotonin 1B receptor mediation. Eur. J. Pharmacol. 135: 279–287. 73 Green, A. R. & G. M. Goodwin 1987. The pharmacology of the hypothermic response of rodents to 8-OH-DPAT administration and the effects of psychotropic drug administration on this response. In Brain 5-HT1A Receptors Behavioural and Neurochemical Pharmacology. C. T. Dourish, S. Ahlenius & P. H. Hutson, Eds. Chichester :Ellis Horwood, pp. 161–198. 74 Maj, J., E. Chojnacka-Wôjcik, A. Klodziniska, A. Derên & E. Moryl 1988. Hypothermia induced by m-trifluoro methylphenyl piperazine or m-chlorophenyl piperazine: an effect mediated by 5-HT1B receptors? J. Neural Trans. 73: 43–55. 75 McKenney, J. D. & R. A. Glennon 1986. TFMPP may produce its stimulus effects via a 5-HT1B mechanism. Pharmacol. Biochem. Behav. 24: 43–47. 76 Glennon, R. A., J. D. McKenney & R. Young 1984. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl) piperazine (TFMPP). Life Sci. 35: 1475–1480. 77 Schechter, M. D. 1986. Tetrahydro-β-carboline may produce its stimulus effects via 5-HT1B receptors. Pharmacol. Biochem. Behav. 28: 1–6. 78 Cunningham, K. A. & J. B. Appel 1986. Possible 5-hydroxytryptamine, (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl) piperazine (TFMPP). J. Pharmacol. Exp. Ther. 237: 369–377. 79 Glennon, R. A., M. E. Pierson & J. D. McKenney 1987. Stimulus generalisation of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine. Pharmacol. Biochem. Behav. 29: 197–199. 80 Frances, H., C. Lienard & J. Fermanian 1990. Improvement of the isolation-induced social behavioural deficit involves activation of the 5-HT1B receptors. Prog. Neuro-Psychopharmacol. & Biol. Psychiatry 14: 91–102. 81 Frances, H. 1988. New animal model of social behavioural deficit: Reversal by drugs. Pharmacol. Biochem. Behav. 29: 467–470. 82 Hoyer, D., A. Pazos, A. Probst & J. M. Palacios 1986. Serotonin receptors in the human brain. I. Characterisation and autoradiographic localisation of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 376: 85–96. 83 Hoyer, D. & D. N. Middlemiss 1989. The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: Evidence for species differences. TIPS 10: 130–132. 84 Sills, M. A., B. B. Wolfe & A. Frazer 1984. Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J. Pharmacol. Exp. Ther. 231: 480–487. 85 Peroutka, S. J. & A. Hamik 1988. [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes. Eur. J. Pharmacol. 148: 297–299. Citing Literature Volume600, Issue1The Neuropharmacology of SerotoninOctober 1990Pages 132-147 ReferencesRelatedInformation